Inhaled RSV therapeutics: Aerosol delivery of novel therapies to the infant lung
- Research Opportunity
- Project Status
- Royal Melbourne Hospital
|A/Professor Paul Licciardi||Personal web page|
|Dr Anushi Rajapaksa||Personal web page|
Does aerosol delivery of palivizumab reduce the severity of RSV disease of RSV infection comparable to intramuscular delivery as determined in a biologically-relevant lamb model?
Faculty Research Themes
School Research Themes
Graduate Research Students who are interested in joining this project will need to consider their elegibility as well as other Graduate Research requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.